Skip to content

Effect of online mindfulness intervention on anxiety, depression, and stress in patients with chronic diseases.

Ying-Ju Chen, Chiu-Hsiang Lee, Chia-Jung Hsieh, Pei-Hung Liao, Yu-Da Chen, Kuei-Ru Chou, Shu-Liu Guo, Li-Fang Chang, Tso-Ying Lee

Explore July 8, 2025 DOI: 10.1016/j.explore.2025.103214 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Qualitative Peer reviewed
Sample size 97
Population Patients with chronic diseases
Intervention Online mindfulness platform
Duration 8-week intervention, assessments at baseline, 4 weeks, and 8 weeks
Topics Anxiety Depression Meditation
Keywords Adults Chronic disease Online mindfulness platform Stress
Citations 1
Key findings Online mindfulness intervention significantly reduced anxiety at 4 and 8 weeks, and reduced depression and stress at 8 weeks, in adults with chronic diseases.

Abstract

Online mindfulness may be an effective non-pharmacological mental health intervention. To evaluate the effectiveness of an online mindfulness platform in ameliorating anxiety, depression, and stress in patients with chronic diseases. In this randomized controlled study, 97 patients were enrolled and randomly assigned to either the online intervention group (N = 47) or the control group (N = 50). Anxiety, depression, and stress levels were assessed at baseline, 4 weeks, and 8 weeks after the intervention. The baseline scores of anxiety, depression, and stress between the control and experiment groups were comparable. Online mindfulness intervention significantly reduced anxiety scores at Week 4 and Week 8 (both P < 0.001). In addition, online mindfulness intervention significantly lowered both depression scores and stress levels at Week 8 (both P ≤ 0.002), but not at Week 4. Online mindfulness interventions effectively alleviate anxiety, depression, and stress in patients with chronic diseases. Future qualitative research is recommended to further explore the mechanisms of change at the psychological level.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics